Clinical precision powered by radiomics & multi-modal AI




































Why partner with Optellum?
Commercial growth
Patient discovery: Identify patients earlier and automatically, developing a funnel for finding more of the right patients.
Patient risk stratification: Optimize care decisions to guide procedures and increase opportunity for neoadjuvant and adjuvant treatments.1,2
Patient acceleration: Accelerate diagnostic care pathway with discovery and prioritization of patients to shorten time to guideline-recommended treatment.1,3
Clinical development
Patient enrollment: Identify the right patients and accelerate enrollment into clinical studies.1,4,5
Predictive biomarkers RUO: Stratify patients earlier and more accurately to support precision care strategies.6-9
Prognostic biomarkers RUO: Assess & monitor therapy response with robust biomarkers and automated volumetric quantification.6-10
Research collaboration
Biomarker & algorithm development: Co-develop cutting-edge image-based biomarkers for diagnosis and therapy guidance.
Study recruitment: Accelerated patient recruitment with image-based endpoints to reduce study participant numbers.
Clinical validation: Validate innovative care pathways and tools with cutting-edge image-based AI and radiomics.
Data sharing
Imaging & installation exchange: Use our clinical solutions at your provider sites in exchange for data.
Data licensing: Access our high-value imaging datasets with flexible licensing options.
Data enrichment: Enrich and integrate our data with yours for research and clinical applications.
Virtual Nodule Clinic Mass+
For Oncology partners
VNC with Tumor Dashboard discovers both lung nodules & masses, which may help clinicians to accelerate referral and prioritize candidates for neoadjuvant treatment.
LungRecur
Powered by LCP AI
Predict the risk of recurrence and support pre-procedural decisions on neo-adjuvant & peri-operative treatment.9
Treatment optimization
Powered by LCP AI
Optimize treatment planning & monitoring for radioenhancer dosing & reliably assess treatment response.
















